SlideShare une entreprise Scribd logo
Toxicology of Modern Medicine

 -Act Now or Repent Later!
Government College of Pharmacy
               Amravati-444304.(M.S.) INDIA.



            Nikam S.J.*, Alone S.S.,
            Kavade V.M., Bhopale A.R.
Objective:-
 new hazards, complications & toxicological effects of modern medicine over
past.


pharmacological reactions, way of escaping indefinite toxicity & awareness to
community.
Pharmaceuticals
                            (Active ingredients)

                                                      Plants


   Health                                                      Isolation

                             Hunger                               &

                    For Chemical Bulk Production           Developing
                                                         chemical Route


 Profit Triumphs                                           Patents
Over Human Sufferings                              Over Discovered Chemicals



               Making P’ceu. Industry most profitable stock market
                                     sector
Always Busy in




                                                                      ter est
                                                                 In
New Drug Discovery & its Development
Inventing effectiveness of Drugs over older one
                                                              of
                                                        ict
                                                    n fl
Manufacturing & How sell increase?
How beneficial a Drug ?
                                               nt co
 Not showing side effects !
                                         Bl ata
Other Reasons:-
                P’ceu. & Medical Research in US
In 2000
            Only 1/3rd
                                    University & Academic
                                    medical centers


Remaining       Research centers run by Pharma Companies.




                         Multinational Pharma companies invest less in
Problems due to Modern Medicine:-



Less clinical trials on New chemical released by Companies

Less potent medications / More toxic & Poisonous effects on other organs

Drug resistant developed with newer drug resistant infections
appearing in many old diseases with changing epidemiology of
many viruses.




Reoccurrence of Poliovirus in Namibia 10 yrs. After Polio-
free (1993-94)

In India, Chikungunya fever after a gap of 30 yrs.
Examples
                         Modern Medicated Refined Sugars




  Overworking of Pancreas causing Insulin resistance &
 Diabetic conditions.


  Affects brain, Hormonal system & reported to be Powerful
 Neurotransmitter


    Releases Wood Alcohol ( Methanol)


   Actually causes person to carve for Sugar & affects Metabolism causing gain in
 body weight.
Newer Antibiotics
Frequently ↑ resistance to modern medications

     “Virtually Untreatable” form of TB emerged

    Resistant to 3 to 6 classes of 2nd line drugs.

    XDRTB (Extreme Drug Resistant Tuberculosis)

   About 4,25,000 cases found in a year for
  MDR-TB (Multi Drug Resistant Tuberculosis).

   Found mostly in China, India& Soviet union
   Houses of Many toxic chemicals




    Among the most widely prescribed of all pharmaceuticals.

  Journal “Drug Safety” indicates that NSAIDs claim
around 3000 lives per year in the UK alone.
   
       people dying annually in US due to Modern Drugs
 prescribed in hospitals & New medical interventions.

Gary Null “Complete Guide to “Health & Nutrition” :- Vit “C”
not commonly prescribe,
 it is not profitable as other syrups & pills prescribed by the
 doctors.
Solutions
  Better Research & long term trials coupled with judicious
use of medicines before launching of any new Drug

  Encourage our age old knowledge of Traditional & Alternative Cures.

  Go Forward for “Integrated Medicine”

                  Alternative (traditional) Drug Therapy




                       Modern System of Medicine.
Acknowledgement
The authors expresses their sincere gratitude towards
Respected
 Mr. Dinesh Gandhi Sir
 Mr. Rahul Akotkar Sir
 Mr. Shailesh Pawade Sir

 for giving their valuable time for work.
References

1)H.K.Parwana,Science Reporter, NISCAIR(CSIR), Vol.45 No.8 August 2008,Pg.No.9-13.
2 Leape, L.L. (1994). Error in medicine. Journal of the American Medical Association 272:
1851-1857.
3)Dr.Carolyn Dean, “Death by Modern Medicine”,Vol.1st Page.no.425.
Toxicology of Modern Medicine

Contenu connexe

Similaire à Toxicology of Modern Medicine

Towards Personalized Medicine
Towards Personalized MedicineTowards Personalized Medicine
Towards Personalized MedicineMichel Dumontier
 
Open Source Pharma Foundation
Open Source Pharma FoundationOpen Source Pharma Foundation
Open Source Pharma FoundationPrateekGarg76472
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyMohammad Mohtashim
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013CincyTechUSA
 
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.Scenario and Strategic Planning: A Case Study of Eli Lily & Co.
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.Yee Jie NG
 
Lean launch pad for Life Sciences and Health Care
Lean launch pad for Life Sciences and Health CareLean launch pad for Life Sciences and Health Care
Lean launch pad for Life Sciences and Health CareStanford University
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalShagufta Farooqui
 
In silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead DiscoveryIn silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead Discoveryinventionjournals
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 PresentationDavid Lester
 
Science As A Business
Science As A BusinessScience As A Business
Science As A BusinessChris Waller
 
White Paper on the Value of Over-the-Counter Medicines
White Paper on the Value of Over-the-Counter MedicinesWhite Paper on the Value of Over-the-Counter Medicines
White Paper on the Value of Over-the-Counter MedicinesYour Health at Hand
 
Drud Discovery - Dr. Amsavel.pdf
Drud Discovery -  Dr. Amsavel.pdfDrud Discovery -  Dr. Amsavel.pdf
Drud Discovery - Dr. Amsavel.pdfDr. Amsavel A
 
Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustrythinkBiotech
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Gezonde scepsis
 
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnCurrent Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnSanjiv Pandey
 
Drug discovery.ppt
Drug discovery.pptDrug discovery.ppt
Drug discovery.pptDeepakRx1
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechMaRS Discovery District
 

Similaire à Toxicology of Modern Medicine (20)

Towards Personalized Medicine
Towards Personalized MedicineTowards Personalized Medicine
Towards Personalized Medicine
 
Open Source Pharma Foundation
Open Source Pharma FoundationOpen Source Pharma Foundation
Open Source Pharma Foundation
 
Drug development and Regulations
Drug development and RegulationsDrug development and Regulations
Drug development and Regulations
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
 
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.Scenario and Strategic Planning: A Case Study of Eli Lily & Co.
Scenario and Strategic Planning: A Case Study of Eli Lily & Co.
 
Lean launch pad for Life Sciences and Health Care
Lean launch pad for Life Sciences and Health CareLean launch pad for Life Sciences and Health Care
Lean launch pad for Life Sciences and Health Care
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug Approval
 
In silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead DiscoveryIn silico Drug Design: Prospective for Drug Lead Discovery
In silico Drug Design: Prospective for Drug Lead Discovery
 
R d disc mngmt
R d disc mngmtR d disc mngmt
R d disc mngmt
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 Presentation
 
Dk1719 fm
Dk1719 fmDk1719 fm
Dk1719 fm
 
Science As A Business
Science As A BusinessScience As A Business
Science As A Business
 
White Paper on the Value of Over-the-Counter Medicines
White Paper on the Value of Over-the-Counter MedicinesWhite Paper on the Value of Over-the-Counter Medicines
White Paper on the Value of Over-the-Counter Medicines
 
Drud Discovery - Dr. Amsavel.pdf
Drud Discovery -  Dr. Amsavel.pdfDrud Discovery -  Dr. Amsavel.pdf
Drud Discovery - Dr. Amsavel.pdf
 
Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology Industry
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010
 
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnCurrent Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Current Medication.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 
Drug discovery.ppt
Drug discovery.pptDrug discovery.ppt
Drug discovery.ppt
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of Biotech
 

Dernier

Advances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdfAdvances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdfDr. M. Kumaresan Hort.
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsCol Mukteshwar Prasad
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptSourabh Kumar
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePedroFerreira53928
 
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringBasic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringDenish Jangid
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345beazzy04
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxakshayaramakrishnan21
 
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxslides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxCapitolTechU
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
 
The basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptxThe basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptxheathfieldcps1
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxShibin Azad
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportAvinash Rai
 
The Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. HenryThe Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. HenryEugene Lysak
 
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17Celine George
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...Sayali Powar
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...Nguyen Thanh Tu Collection
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfVivekanand Anglo Vedic Academy
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticspragatimahajan3
 

Dernier (20)

Advances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdfAdvances in production technology of Grapes.pdf
Advances in production technology of Grapes.pdf
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringBasic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
 
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
Operations Management - Book1.p  - Dr. Abdulfatah A. SalemOperations Management - Book1.p  - Dr. Abdulfatah A. Salem
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptx
 
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxslides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptxThe basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptx
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptx
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
The Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. HenryThe Last Leaf, a short story by O. Henry
The Last Leaf, a short story by O. Henry
 
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 2 STEPS Using Odoo 17
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
NCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdfNCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdf
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceutics
 

Toxicology of Modern Medicine

  • 1. Toxicology of Modern Medicine -Act Now or Repent Later!
  • 2. Government College of Pharmacy Amravati-444304.(M.S.) INDIA. Nikam S.J.*, Alone S.S., Kavade V.M., Bhopale A.R.
  • 3. Objective:-  new hazards, complications & toxicological effects of modern medicine over past. pharmacological reactions, way of escaping indefinite toxicity & awareness to community.
  • 4. Pharmaceuticals (Active ingredients) Plants Health Isolation Hunger & For Chemical Bulk Production Developing chemical Route Profit Triumphs Patents Over Human Sufferings Over Discovered Chemicals Making P’ceu. Industry most profitable stock market sector
  • 5. Always Busy in ter est In New Drug Discovery & its Development Inventing effectiveness of Drugs over older one of ict n fl Manufacturing & How sell increase? How beneficial a Drug ? nt co  Not showing side effects ! Bl ata
  • 6. Other Reasons:- P’ceu. & Medical Research in US In 2000 Only 1/3rd University & Academic medical centers Remaining Research centers run by Pharma Companies. Multinational Pharma companies invest less in
  • 7.
  • 8. Problems due to Modern Medicine:- Less clinical trials on New chemical released by Companies Less potent medications / More toxic & Poisonous effects on other organs Drug resistant developed with newer drug resistant infections appearing in many old diseases with changing epidemiology of many viruses. Reoccurrence of Poliovirus in Namibia 10 yrs. After Polio- free (1993-94) In India, Chikungunya fever after a gap of 30 yrs.
  • 9. Examples Modern Medicated Refined Sugars Overworking of Pancreas causing Insulin resistance & Diabetic conditions. Affects brain, Hormonal system & reported to be Powerful Neurotransmitter Releases Wood Alcohol ( Methanol) Actually causes person to carve for Sugar & affects Metabolism causing gain in body weight.
  • 10. Newer Antibiotics Frequently ↑ resistance to modern medications “Virtually Untreatable” form of TB emerged Resistant to 3 to 6 classes of 2nd line drugs. XDRTB (Extreme Drug Resistant Tuberculosis) About 4,25,000 cases found in a year for MDR-TB (Multi Drug Resistant Tuberculosis). Found mostly in China, India& Soviet union
  • 11. Houses of Many toxic chemicals Among the most widely prescribed of all pharmaceuticals. Journal “Drug Safety” indicates that NSAIDs claim around 3000 lives per year in the UK alone.
  • 12.        people dying annually in US due to Modern Drugs prescribed in hospitals & New medical interventions. Gary Null “Complete Guide to “Health & Nutrition” :- Vit “C” not commonly prescribe, it is not profitable as other syrups & pills prescribed by the doctors.
  • 13. Solutions Better Research & long term trials coupled with judicious use of medicines before launching of any new Drug Encourage our age old knowledge of Traditional & Alternative Cures. Go Forward for “Integrated Medicine” Alternative (traditional) Drug Therapy Modern System of Medicine.
  • 14. Acknowledgement The authors expresses their sincere gratitude towards Respected Mr. Dinesh Gandhi Sir Mr. Rahul Akotkar Sir Mr. Shailesh Pawade Sir for giving their valuable time for work.
  • 15. References 1)H.K.Parwana,Science Reporter, NISCAIR(CSIR), Vol.45 No.8 August 2008,Pg.No.9-13. 2 Leape, L.L. (1994). Error in medicine. Journal of the American Medical Association 272: 1851-1857. 3)Dr.Carolyn Dean, “Death by Modern Medicine”,Vol.1st Page.no.425.